These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 36767803)

  • 1. No Causal Effects Detected in COVID-19 and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Two Sample Mendelian Randomization Study.
    Xu W; Cao Y; Wu L
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal Effects between Gut Microbiome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Two-Sample Mendelian Randomization Study.
    He G; Cao Y; Ma H; Guo S; Xu W; Wang D; Chen Y; Wang H
    Front Microbiol; 2023; 14():1190894. PubMed ID: 37485509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
    Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
    JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
    Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
    Front Immunol; 2022; 13():949787. PubMed ID: 36341457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DecodeME: community recruitment for a large genetics study of myalgic encephalomyelitis / chronic fatigue syndrome.
    Devereux-Cooke A; Leary S; McGrath SJ; Northwood E; Redshaw A; Shepherd C; Stacey P; Tripp C; Wilson J; Mar M; Boobyer D; Bromiley S; Chowdhury S; Dransfield C; Almas M; Almelid Ø; Buchanan D; Garcia D; Ireland J; Kerr SM; Lewis I; McDowall E; Migdal M; Murray P; Perry D; Ponting CP; Vitart V; Wolfe JC
    BMC Neurol; 2022 Jul; 22(1):269. PubMed ID: 35854226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome After SARS-CoV-2 Infection.
    Unger ER; Lin JS; Wisk LE; Yu H; L'Hommedieu M; Lavretsky H; Montoy JCC; Gottlieb MA; Rising KL; Gentile NL; Santangelo M; Venkatesh AK; Rodriguez RM; Hill MJ; Geyer RE; Kean ER; Saydah S; McDonald SA; Huebinger R; Idris AH; Dorney J; Hota B; Spatz ES; Stephens KA; Weinstein RA; Elmore JG;
    JAMA Netw Open; 2024 Jul; 7(7):e2423555. PubMed ID: 39046739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Campen CLMCV; Rowe PC; Visser FC
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Lv Y; Zhang T; Cai J; Huang C; Zhan S; Liu J
    Front Immunol; 2022; 13():952987. PubMed ID: 36189286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Thyroid Function: A Bi-Directional Two-Sample Mendelian Randomization Study.
    Li GH; Tang CM; Cheung CL
    Thyroid; 2022 Sep; 32(9):1037-1050. PubMed ID: 35734897
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.
    Yoshikawa M; Asaba K; Nakayama T
    BMC Med Genomics; 2021 Nov; 14(1):269. PubMed ID: 34774031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using genetic variants to evaluate the causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study.
    Cui Z; Tian Y
    J Transl Med; 2021 Jul; 19(1):300. PubMed ID: 34246301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The causal relationship between COVID-19 and seventeen common digestive diseases: a two-sample, multivariable Mendelian randomization study.
    Wang Z; Zhou H; Zhang S; Wang F; Huang H
    Hum Genomics; 2023 Sep; 17(1):87. PubMed ID: 37752570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study.
    Retornaz F; Rebaudet S; Stavris C; Jammes Y
    J Transl Med; 2022 Sep; 20(1):429. PubMed ID: 36153556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses.
    Nunes JM; Kell DB; Pretorius E
    Blood Rev; 2023 Jul; 60():101075. PubMed ID: 36963989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology.
    Wong TL; Weitzer DJ
    Medicina (Kaunas); 2021 Apr; 57(5):. PubMed ID: 33925784
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID.
    Tate WP; Walker MOM; Peppercorn K; Blair ALH; Edgar CD
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
    Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
    J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome.
    Komaroff AL; Lipkin WI
    Trends Mol Med; 2021 Sep; 27(9):895-906. PubMed ID: 34175230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Sasso EM; Muraki K; Eaton-Fitch N; Smith P; Lesslar OL; Deed G; Marshall-Gradisnik S
    Mol Med; 2022 Aug; 28(1):98. PubMed ID: 35986236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors?
    Mantovani E; Mariotto S; Gabbiani D; Dorelli G; Bozzetti S; Federico A; Zanzoni S; Girelli D; Crisafulli E; Ferrari S; Tamburin S
    J Neurovirol; 2021 Aug; 27(4):631-637. PubMed ID: 34341960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.